HOYA (7741) AI Stock Analysis

• Market Cap: ¥6.68T
• Dividend Yield: 0.82%
• Average Volume (3M): 1.15M
• Price to Earnings (P/E): 33.5
• Beta (1Y): 1.00
• Revenue Growth: 13.56%
• EPS Growth: 12.78%
• Country: JP
• Employees: 35,702
• Sector: Healthcare
• Sector Strength: 42
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 149.46
• Shares Outstanding: 343,122,620
• 10 Day Avg. Volume: 1,121,230
• 30 Day Avg. Volume: 1,150,486
• PEG Ratio: -19.38
• Price to Book (P/B): 6.42
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 32.95
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥21,975.35
• Price Target Upside: 12.67% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 4

• Rating: 75 Outperform
• Price Target: ¥19,127.00 ▼(-1.94%Downside)

HOYA's strong financial performance is the most significant factor, showcasing impressive revenue growth and a robust balance sheet. While technical analysis shows bullish trends, overbought indicators suggest caution. The valuation component indicates a higher P/E ratio, reflecting potential overvaluation. The absence of earnings call and corporate events data did not affect the score.

Positive Factors

Capacity Expansion

Hoya is operating at full capacity and is building more capacity to meet future demand.

IT Sector Growth

IT revenue grew 33% and operating profit grew 42% year-over-year, exceeding estimates by 16%.

Operating Performance

Operating profit of ¥66bn grew 24% year-over-year, with an operating margin of 30% that is 40 basis points ahead of consensus.

Negative Factors

Missed Profit Estimates

Operating profit of ¥24.7bn fell short of estimates by 15%, attributed to ongoing investments.

Net Income Decline

Net income of ¥51.5bn was 10% lower year-over-year, aligning with consensus due to a foreign exchange loss of ¥0.4bn.

One-off Write Down

Net income of ¥50.5bn increased 32% year-over-year, but was 7% below consensus due to a one-off write down of 4.8bn yen in the life care segment.

HOYA Business Overview & Revenue Model

Company Description

HOYA Corporation, headquartered in Tokyo, Japan, is a diversified technology and healthcare company. It operates primarily in two sectors: Life Care and Information Technology. In the Life Care segment, HOYA provides products such as eyeglass lenses, contact lenses, and endoscopic imaging devices. The Information Technology segment focuses on manufacturing electronic components, including photomasks and hard disk drive (HDD) substrates. HOYA is recognized for its innovative technologies and solutions that enhance optical performance and contribute to healthcare advancements.

How the Company Makes Money

HOYA Corporation generates revenue through the sale of products and services across its two main business segments: Life Care and Information Technology. In the Life Care segment, the company earns money through the production and sale of optical health products, such as eyeglass lenses and contact lenses, which are distributed globally. Additionally, HOYA's medical division provides endoscopic imaging devices and other health-related technologies, contributing significantly to its income. In the Information Technology segment, HOYA supplies electronic components such as photomasks, which are essential in semiconductor manufacturing, and HDD substrates used in data storage. These products are pivotal in the technology supply chain, facilitating stable and recurring revenue streams. The company's strategic partnerships with leading global manufacturers and its investment in research and development bolster its market position and provide competitive advantages, enabling sustained revenue growth.

HOYA Financial Statement Overview

Summary

HOYA exhibits strong financial performance, with impressive revenue growth and profitability. The balance sheet is robust, with low leverage and a high equity ratio, mitigating financial risks. Cash flow metrics are positive, although there is some potential to enhance cash conversion efficiency. Overall, the company is financially sound and well-positioned for future growth.

Income Statement

HOYA has demonstrated strong revenue growth with a 13.6% increase from 2024 to 2025. The gross profit margin remains robust at 80.1%, indicating effective cost management. The net profit margin at 23.3% reflects solid profitability. However, the EBIT margin decreased significantly from 46.4% in 2024 to 28.8% in 2025, suggesting rising operating expenses or other challenges impacting operations.

Balance Sheet

The balance sheet is strong with a low debt-to-equity ratio of 0.04, indicating minimal leverage. The equity ratio of 78.9% showcases financial stability and a solid equity base. Return on equity stands at 20.7%, reflecting efficient use of shareholder funds. The company's financial health is well-managed with low potential risks related to debt.

Cash Flow

HOYA's free cash flow grew by 3% from 2024 to 2025, showcasing consistent cash generation. The operating cash flow to net income ratio is 1.16, indicating strong cash generation relative to reported profits. However, the free cash flow to net income ratio of 0.93 suggests some room for improvement in cash conversion efficiency.

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	866.03B	762.61B	734.10B	670.33B	558.26B
Gross Profit	693.58B	421.69B	631.86B	567.28B	474.98B
EBITDA	309.61B	284.45B	259.78B	243.96B	200.27B
Net Income	202.10B	181.38B	168.64B	164.51B	125.45B
Balance Sheet
Total Assets	1.23T	1.20T	1.03T	992.84B	853.29B
Cash, Cash Equivalents and Short-Term Investments	533.97B	525.16B	426.27B	426.63B	338.79B
Total Debt	37.28B	29.24B	24.58B	21.60B	20.75B
Total Liabilities	262.65B	241.36B	213.72B	203.78B	180.88B
Stockholders Equity	974.02B	967.76B	818.32B	803.85B	688.00B
Cash Flow
Free Cash Flow	187.19B	181.73B	168.36B	161.18B	120.57B
Operating Cash Flow	235.11B	222.80B	201.83B	190.06B	151.81B
Investing Cash Flow	-33.19B	-35.81B	-47.50B	-29.30B	-29.79B
Financing Cash Flow	-190.35B	-110.89B	-194.59B	-106.72B	-115.67B

HOYA Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 19505.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7741, the sentiment is Positive. The current price of 19505 is above the 20-day moving average (MA) of 17817.50, above the 50-day MA of 17407.20, and above the 200-day MA of 18530.65, indicating a bullish trend. The MACD of 572.95 indicates Negative momentum. The RSI at 73.25 is Negative, neither overbought nor oversold. The STOCH value of 92.46 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7741.

HOYA Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6869	79 Outperform	¥1.57T	29.30	11.84%	1.19%	10.21%	8.55%
7733	76 Outperform	$2.01T	17.36	15.47%	1.10%	6.53%	-46.94%
7741	75 Outperform	¥6.68T	33.55	20.56%	0.82%	13.56%	12.78%
4543	73 Outperform	$3.83T	32.78	8.56%	1.00%	12.40%	10.46%
7747	72 Outperform	¥651.36B	61.85	7.09%	1.01%	17.38%	-30.54%
Sector *	65 Neutral	¥355.15B	11.37	-2.99%	2.48%	11.78%	-10.17%
8086	57 Neutral	€225.40B	44.08	2.07%	2.32%	9.85%	-53.97%

HOYA Corporate Events

HOYA Corporation Announces Strategic Restructuring of Endoscope Business

HOYA Corporation announced a strategic move to transfer its endoscope business in Japan to a newly established wholly owned subsidiary, PENTAX Medical Corporation, through a simplified absorption-type company split effective May 1, 2026. This restructuring aims to enhance the business’s growth by allowing PENTAX Medical to make more focused decisions on product development, sales, and compliance, aligning with the industry’s specific needs and potentially strengthening HOYA’s market position.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen22575.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA Corporation Extends Performance-Based Stock Compensation Plan

HOYA Corporation has announced the continuation of its Performance Share Unit plan, a stock compensation initiative aimed at motivating executive officers to achieve long-term business goals and enhance corporate value. This plan, which involves granting shares based on performance targets, is designed to retain top talent and align executive interests with company growth, impacting the company’s strategic positioning and stakeholder interests.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen22575.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA Wins Partial Court Ruling on Tax Reassessment

HOYA Corporation has received a favorable ruling from the Tokyo District Court, which cancels approximately ¥1.3 billion in taxes related to a reassessment based on transfer pricing taxation. Despite this partial victory, HOYA plans to appeal the remaining portions of the court’s decision, though the outcome is not expected to significantly impact the company’s consolidated financial performance.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen22575.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA Corporation Introduces New Executive Stock Compensation Plan

HOYA Corporation has introduced a new stock compensation plan called ‘Restricted Stock Units’ for its Executive Officers, aiming to enhance motivation and align their interests with the company’s long-term value. This plan, which includes specific provisions for share allocation and monetary payouts, is designed to secure top talent by making compensation competitive with global standards, potentially impacting the company’s operational efficiency and market positioning.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen22575.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA Corporation Increases Year-End Dividend to Enhance Shareholder Returns

HOYA Corporation announced a significant increase in its year-end dividend for the fiscal year ended March 31, 2025, reflecting its commitment to maximizing corporate value and shareholder returns. The company aims to balance growth investments with stable dividends, highlighting a progressive dividend policy with a target payout ratio of 40%, while the dividend forecast for the next fiscal year remains undetermined.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen22575.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA Corporation Revises Dividend Policy to Boost Shareholder Returns

HOYA Corporation announced a revision of its dividend policy, introducing a progressive dividend policy with a target payout ratio of 40% to enhance capital efficiency and shareholder returns. This change reflects the company’s strategy to balance growth investments with shareholder returns, resulting in a significant increase in the year-end dividend forecast by 45% compared to the previous fiscal year.

HOYA Corporation Reports Significant Financial Growth in FY2025

HOYA Corporation reported a significant increase in its non-consolidated full-year financial results for the fiscal year ending March 31, 2025, compared to the previous year. The company experienced an 8.5% rise in net sales and a substantial increase in ordinary and net income, attributed to strong performance in its Information Technology business and increased dividend income from affiliated companies.

HOYA CORPORATION Announces Treasury Stock Cancellation to Boost Capital Efficiency

HOYA CORPORATION has announced the cancellation of 2,736,600 shares of its treasury stock, representing 0.79% of its total outstanding shares, to increase capital efficiency and enhance shareholder benefits. This strategic move, scheduled for completion on May 14, 2025, aims to reduce the total number of outstanding shares, potentially impacting the company’s market value and shareholder returns positively.